Yesterday, the U.S. Food and Drug Administration (FDA) updated its website to provide new information on data integrity concerns relating to ...

A new study analyzing the FDA's Manufacturer and User Facility Device Experience database found that nearly one-third of medical device safety reports were not submitted within the 30-day timeframe or ...

U.S. President Donald Trump and billionaire Elon Musk are undertaking a sweeping campaign to slash the size of the ...

Q4 2024 Earnings Call Transcript March 13, 2025 Operator: Hello, and welcome to Nyxoah Fourth Quarter 2024 Earnings ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

Good afternoon. Welcome to the Liquidmetal Technologies Fiscal Year 2024 Conference Call. My name is Lisa, and I'll be your conference operator this afternoon. Joining us on today's call is Mr. Tony ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

Early voting starts Saturday. The ballot for the March 29 election has four constitutional amendments on courts, taxes, ...

The U.S. FDA issues flu vaccine strain recommendations for 2025-2026 on its own without advisory input. Read more here.

The Health and Human Services Secretary directed the FDA to consider eliminating a pathway that allowed companies to "self-affirm" whether their ingredients are safe for consumption.

Highlighted potential long-term benefits of INB-200. As of October 18, 2024, five patients remained alive, three patients had ...